ADH is a hormone stored in the posterior pituitary gland in the brain, regulating water levels in the body. ADH interacts with the kidneys to increase total body water increasing blood volume and blood pressure. The release of ADH is controlled by cells called osmoreceptors and baroreceptors.

The global Antidiuretic Hormone (ADH) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antidiuretic Hormone (ADH) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antidiuretic Hormone (ADH) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Novartis
Pfizer
Fresenius Kabi
Par Pharmaceutical
Ferring Pharmaceuticals
Astellas Pharma
Shanghai Soho-Yiming Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection

Segment by Application
Anti-Diuretic Hormone Deficiency
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia & Fibrillation